We are live on ! Find out more
FC

Fairpointe Capital Portfolio holdings

AUM $66.3M
1-Year Est. Return 101.32%
This Fund
S&P 500
This Quarter Est. Return
+7.46%
1 Year Est. Return
+101.32%
3 Year Est. Return
+48.06%
5 Year Est. Return
+95.29%
10 Year Est. Return
AUM
$5.95B
AUM Growth
+$968M
Cap. Flow
+$572M
Cap. Flow %
9.61%
Top 10 Hldgs %
31.15%
Holding
77
New
5
Increased
36
Reduced
29
Closed
2

Top Buys

Rank Stock Value
1
XYL icon
Xylem
XYL
+$166M
2
AGCO icon
AGCO
AGCO
+$114M
3
RJF icon
Raymond James Financial
RJF
+$105M
4
CTXS
Citrix Systems Inc
CTXS
+$93.7M
5
WOLF icon
Wolfspeed
WOLF
+$49.2M

Sector Composition

Rank Sector Weight
1 Technology 28.24%
2 Industrials 17.22%
3 Healthcare 10.92%
4 Communication Services 10.04%
5 Financials 7.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FRX
26
DELISTED
FOREST LABORATORIES INC
FRX
$116M 1.95%
2,715,478
-77,021
-3% -$3.35M
BG icon
27
Bunge Global
BG
$20.9B
$116M 1.95%
1,526,543
+278,327
+22% +$21.1M
CRL icon
28
Charles River Laboratories
CRL
$11.3B
$109M 1.83%
2,349,642
+45,034
+2% +$2.07M
CNW
29
DELISTED
CON-WAY INC.
CNW
$105M 1.76%
2,437,412
-254,140
-9% -$10.8M
LXK
30
DELISTED
Lexmark Intl Inc
LXK
$104M 1.75%
3,156,836
-651,193
-17% -$23.1M
RJF icon
31
Raymond James Financial
RJF
$33.5B
$101M 1.7%
+3,647,976
New +$105M
FSLR icon
32
First Solar
FSLR
$21.4B
$101M 1.69%
2,506,090
+303,143
+14% +$12.8M
CTXS
33
DELISTED
Citrix Systems Inc
CTXS
$94.2M 1.58%
+1,675,109
New +$93.7M
MOLXA
34
DELISTED
MOLEX INC CL-A
MOLXA
$93.4M 1.57%
2,439,226
-27,673
-1% -$1.06M
ZBRA icon
35
Zebra Technologies
ZBRA
$13.5B
$90.7M 1.52%
1,991,009
-15,962
-0.8% -$736K
MOLX
36
DELISTED
MOLEX INC
MOLX
$90.6M 1.52%
2,352,583
-12,709
-0.5% -$408K
LEA icon
37
Lear
LEA
$7.39B
$85.6M 1.44%
1,196,421
-94,515
-7% -$6.51M
LHX icon
38
L3Harris
LHX
$55.4B
$82.4M 1.39%
1,389,993
-154,928
-10% -$8.63M
SIAL
39
DELISTED
SIGMA - ALDRICH CORP
SIAL
$82.4M 1.39%
966,301
-2,685
-0.3% -$226K
SCHL icon
40
Scholastic
SCHL
$774M
$74M 1.24%
2,582,198
+360,709
+16% +$11M
CINF icon
41
Cincinnati Financial
CINF
$27.8B
$72.3M 1.22%
1,533,557
+115,590
+8% +$5.52M
MHFI
42
DELISTED
MCGRAW-HILL FINANCIAL INC COM
MHFI
$69.8M 1.17%
1,063,561
-524,984
-33% -$31.8M
EV
43
DELISTED
Eaton Vance Corp.
EV
$68.2M 1.15%
1,755,707
+58,459
+3% +$2.33M
BWA icon
44
BorgWarner
BWA
$12.8B
$61.7M 1.04%
1,381,567
-262,509
-16% -$11M
FDS icon
45
Factset
FDS
$10B
$61.4M 1.03%
562,817
+142,652
+34% +$15.4M
BLC
46
DELISTED
BELO CORP SER A
BLC
$57.9M 0.97%
4,227,313
-1,614,739
-28% -$22.8M
FMC icon
47
FMC
FMC
$1.25B
$56.2M 0.94%
903,419
-124,070
-12% -$7.12M
HRB icon
48
H&R Block
HRB
$5.98B
$47.8M 0.8%
1,793,931
-446,965
-20% -$13M
IWR icon
49
iShares Russell Mid-Cap ETF
IWR
$55.9B
$33.9M 0.57%
976,400
+821,200
+529% +$28.1M
PPO
50
DELISTED
POLYPORE INTERNATIONAL, INC
PPO
$30.1M 0.51%
734,094
+258,850
+54% +$11M

Similar funds

Fairpointe Capital's Q3 2013 Portfolio in Review

As of Q3 2013, Fairpointe Capital held 77 positions worth $5.95B, up 19% from $4.98B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Fairpointe Capital deployed $572M of net new capital in Q3 2013, opening 5 new positions and adding to 36 existing holdings. Its largest new stake was Xylem: 6,216,702 shares worth $174M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 28% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Boston Scientific, an estimated $93.9M trimmed.

  • Fairpointe Capital's largest Q3 2013 buy was Xylem: 6,216,702 shares worth $174M.
  • Fairpointe Capital added most to Wolfspeed in Q3 2013, an estimated $49.2M increase.
  • Fairpointe Capital's biggest Q3 2013 reduction was Boston Scientific, cutting an estimated $93.9M.
  • Fairpointe Capital fully exited Denbury Resources, Inc. in Q3 2013, selling an estimated $15.6M.
  • Fairpointe Capital's ten largest holdings make up 31% of its $5.95B portfolio in Q3 2013.
  • Fairpointe Capital opened 5 new positions and closed 2 in Q3 2013.
  • Fairpointe Capital's portfolio value rose 19% quarter-over-quarter to $5.95B.

Based on Fairpointe Capital's 13F filing for Q3 2013, filed 12 Nov 2013.